Vadodara

To support for commercial troubleshooting/remediation/Market complaints for Non-Oral manufacturing sites. To support for timely investigation/execution and to resume commercial manufacturing and to meet market/ sales requirement.

Diploma in Pharmacy. Candidates must be from the 2025 graduating batch with no active backlogs or ATKT.

Solid Oral Formulation Development, QbD, Scale-Up, Pilot Batches & Tech Transfer. Literature Review & Excipient Compatibility.

Master of Pharmacy Participation in Investigations, Root cause analysis and proposing relevant CAPAs against OOS: OOT: incident, and change control complaints and audit observations to QMS team.

Preparation of registration strategy for Brazil submission. Prepare response to deficiency letter received from Anvisa, Brazil. Sun Pharma, Executive Regulatory and Business Continuity

GPAT 2026 is a national level examination for award of scholarship to qualified candidates seeking entry into Master of Pharmacy M.Pharm course. 

To design and conduct experiments for preformulation, formulation optimization of Microsphere and long acting complex non oral dosage form based on QbD approach.

Graduation : B.Pharm with post-graduation : M.Pharm / MBA (Pharma Management). Develop and implement brand strategies and marketing plans.

Responsible for executing technology transfer activities for injectable dosage forms, including planning and performing Scale-up, Exhibit and Process Validation batches with optimal utilization of manpower, materials, and equipment.